The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period.

Friday, November 2, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs

Read the full report: https://www.reportlinker.com/p05605442 The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast
period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 241-page report you will receive 85 tables and 103 figures– all unavailable elsewhere.The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope- Cell-based Assays market forecasts from 2018-2028Cell-Based Assays Market by Product Type:- Instrument- Consumables- Software- Services- Reagents- Assay Kits- Microplates- Cell Lines- Probes & LabelsCell-Based Assays Market by Application:- Drug Discovery- Basic Research- Predictive TechnologyCell-based Assays Market by End-User:- Pharma & Biotech Companies- Academic Institutes- CROsThis report provides individual revenue forecasts to 2028 for these national markets:- US- Japan- Germany- UK- France- Spain- Italy- China- India- Russia- Brazil- Our study includes SWOT and STEP analysis of the cell-based assays market.Our study discusses the selected leading companies that are the major players in the cell-based assays market:- BD (Becton, Dickinson and Company)- BioAgilytix Labs- BioVision- Cell Assay Innovations, Inc.- Charles River Laboratories International- CYTOO SA- DiscoverX- GE Healthcare- InSphero- Marin Biological Laboratories- Molecular Devices- Perkin Elmer- Pharmaceutical Product Development- Porsolt- Promega- ProQinase GmbH- QGel- SGS Group, Inc.- Thermo Fisher Scientific (and Affymetrix acquisition)- This report also discusses technology, trends and future outlook of the cell-based assays industryRead the full report: https://www.reportlinker.com/p05605442 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-revenue-of-the-cell-based-assays-market-in-2017-is-estimated-at-13bn-and-is-expected-to-grow-at-a-cagr-of-9-2-in-the-first-half-of-the-forecast-period-300742326.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store